Home The Word Brain My Amedeo FAQ Privacy About Flying Publisher   

The Angels Initiative

Stroke prevention

  Kidney Transplantation

  Free Subscription

Articles published in Kidney Int

Retrieve available abstracts of 84 articles:
HTML format

Single Articles

    November 2022
  1. MEINDERTS JR, Schreuder MF, de Jong MFC
    Pregnancy after kidney transplantation: more attention is needed for long-term follow-up of the offspring.
    Kidney Int. 2022;102:1190-1191.

  2. HAAS M, Mirocha J, Huang E, Najjar R, et al
    A Banff-based histologic chronicity index is associated with graft loss in patients with a kidney transplant and antibody-mediated rejection.
    Kidney Int. 2022 Nov 1. pii: S0085-2538(22)00912.
    PubMed     Abstract available

    October 2022
  3. MOREAU A, Kervella D, Bouchet-Delbos L, Braudeau C, et al
    A Phase I/IIa study of autologous tolerogenic dendritic cells immunotherapy in kidney transplant recipients.
    Kidney Int. 2022 Oct 25. pii: S0085-2538(22)00845.
    PubMed     Abstract available

  4. JESUDASON S, Piccoli GB
    Pregnancy outcomes after kidney transplantation: the challenges of success.
    Kidney Int. 2022;102:697-699.
    PubMed     Abstract available

    September 2022
  5. ROSEN RJ, Prakash-Polet S, Liu P, Batal I, et al
    The Case | An unusual cause of proteinuria in a kidney transplant recipient.
    Kidney Int. 2022;102:673-674.

  6. KIBERD BA, Lim WH
    The windows of opportunity.
    Kidney Int. 2022;102:479-481.
    PubMed     Abstract available

  7. GIARRATANO Y, Pugh D, Farrah TE, Oniscu GC, et al
    Novel retinal vascular phenotypes for the potential assessment of long-term risk in living kidney donors.
    Kidney Int. 2022;102:661-665.

    August 2022
  8. BENOTMANE I, Velay A, Vargas GG, Olagne J, et al
    A rapid decline in the anti-receptor binding domain of the SARS-CoV-2 spike protein IgG titer in kidney transplant recipients after tixagevimab-cilgavimab administration.
    Kidney Int. 2022 Aug 13. pii: S0085-2538(22)00616.

  9. CACHO J, Nicolas D, Bodro M, Cuadrado-Payan E, et al
    Kidney Int. 2022 Aug 11. pii: S0085-2538(22)00613.

  10. BOU SABA J, Cherukuri A
    Antigen-specific B cells in kidney transplantation.
    Kidney Int. 2022;102:233-235.
    PubMed     Abstract available

    July 2022
  11. KAMINSKI H, Gigan M, Vermorel A, Charrier M, et al
    Covid-19 morbidity decreases with Tixagevimab/cilgavimab preexposure prophylaxis in kidney transplant recipients non/low vaccine responders.
    Kidney Int. 2022 Jul 20. pii: S0085-2538(22)00550.

  12. MANOHARAN K, Gupta P, Mehta H, Nada R, et al
    The Case | Inflammatory polyarthritis in a kidney transplant recipient.
    Kidney Int. 2022;102:215-216.

  13. JAMHOUR-CHELH K, Melendo-Viu M, Dobarro D, Raposeiras-Roubin S, et al
    Acute heart failure in a kidney transplant patient.
    Kidney Int. 2022;102:211.

  14. VAN LOON E, Lamarthee B, de Loor H, Van Craenenbroeck AH, et al
    Biological pathways and comparison with biopsy signals and cellular origin of peripheral blood transcriptomic profiles during kidney allograft pathology.
    Kidney Int. 2022;102:183-195.
    PubMed     Abstract available

    June 2022
  15. GOSSELINK ME, van Buren MC, Kooiman J, Groen H, et al
    A nationwide Dutch cohort study shows relatively good pregnancy outcomes after kidney transplantation and finds risk factors for adverse outcomes.
    Kidney Int. 2022 Jun 28. pii: S0085-2538(22)00468.
    PubMed     Abstract available

  16. SCHOLD JD, Huml AM, Poggio ED, Reese PP, et al
    A tool for decision-making in kidney transplant candidates with poor prognosis to receive deceased donor transplantation in the United States.
    Kidney Int. 2022 Jun 24. pii: S0085-2538(22)00462.
    PubMed     Abstract available

  17. ANDERSON B, Qasim M, Evison F, Gallier S, et al
    A population cohort analysis of English transplant centers indicates major adverse cardiovascular events after kidney transplantation.
    Kidney Int. 2022 Jun 15. pii: S0085-2538(22)00450.
    PubMed     Abstract available

  18. VAN DER WEIJDEN J, Mahesh SVK, van Londen M, Bakker SJL, et al
    Early increase in single-kidney glomerular filtration rate after living kidney donation predicts long-term kidney function.
    Kidney Int. 2022;101:1251-1259.
    PubMed     Abstract available

    May 2022
  19. SURI RS, Lee JY, Ban MR, Shrum B, et al
    Defective KIM-1 phagocytosis does not predispose to acute graft dysfunction after kidney transplantation in humans.
    Kidney Int. 2022 May 27. pii: S0085-2538(22)00381.

  20. MONTAGUD-MARRAHI E, Cuadrado-Payan E, Hermida E, Cacho J, et al
    Preemptive simultaneous pancreas kidney transplantation has survival benefit to patient.
    Kidney Int. 2022 May 26. pii: S0085-2538(22)00385.
    PubMed     Abstract available

  21. BERTRAND D, Laurent C, Lemee V, Lebourg L, et al
    Efficacy of anti SARS-CoV-2 monoclonal antibodies prophylaxis and vaccination on Omicron COVID-19 in kidney transplant recipients.
    Kidney Int. 2022 May 23. pii: S0085-2538(22)00382.

  22. BASU S, Dorling A
    Regulation of T- and B-cell interactions determines the clinical phenotype associated with donor-specific antibodies.
    Kidney Int. 2022;101:877-879.
    PubMed     Abstract available

    April 2022
  23. BURTON H, McLaughlin L, Shiu KY, Shaw O, et al
    The phenotype of HLA-binding B-cells from sensitized kidney transplant recipients correlates with clinically prognostic patterns of interferon-gamma production against purified HLA proteins.
    Kidney Int. 2022 Apr 25. pii: S0085-2538(22)00339.
    PubMed     Abstract available

  24. AL JURDI A, Gassen RB, Borges TJ, Lape IT, et al
    Suboptimal antibody response against SARS-CoV-2 Omicron variant after third dose of mRNA vaccine in kidney transplant recipients.
    Kidney Int. 2022 Apr 13. pii: S0085-2538(22)00288.

  25. CHAVAROT N, Melenotte C, Amrouche L, Rouzaud C, et al
    Early treatment with sotrovimab monoclonal antibody in kidney transplant recipients with Omicron infection.
    Kidney Int. 2022 Apr 11. pii: S0085-2538(22)00272.

  26. HUANG E, Jordan SC
    Donor-derived cell-free DNA in kidney transplantation: evolving concepts and potential limitations.
    Kidney Int. 2022;101:676-677.
    PubMed     Abstract available

  27. LASSEN E, Daehn IS
    Hypertrophy and glomerular cell adaptation through crosstalk leads to glomerular injury after kidney transplantation.
    Kidney Int. 2022;101:673-676.
    PubMed     Abstract available

  28. LOGEL SN, Connor EL, Paloian NJ
    The Case | A 17-year-old boy with growth failure and chronic kidney disease.
    Kidney Int. 2022;101:837-838.

    March 2022
  29. PERKINS GB, Tunbridge M, Salehi T, Chai CS, et al
    Concurrent vaccination of kidney transplant recipients and close household cohabitants against COVID-19.
    Kidney Int. 2022 Mar 15. pii: S0085-2538(22)00172.

  30. SUWELACK B, Berger K, Wolters H, Gerss JWO, et al
    Results of the prospective multicenter SoLKiD cohort study indicate bio-psycho-social outcome risks to kidney donors 12 months after donation.
    Kidney Int. 2022;101:597-606.
    PubMed     Abstract available

    February 2022
  31. BENOTMANE I, Bruel T, Planas D, Fafi-Kremer S, et al
    A fourth dose of the mRNA-1273 SARS-CoV-2 vaccine improves serum neutralization against the delta variant in kidney transplant recipients.
    Kidney Int. 2022 Feb 26. pii: S0085-2538(22)00168.

  32. MASSET C, Benotmane I, Dantal J, Garandeau C, et al
    A fourth SARS-Cov-2 mRNA vaccine in strictly seronegative kidney transplant recipients.
    Kidney Int. 2022 Feb 12. pii: S0085-2538(22)00093.

  33. ERPICUM P, Grosch S, Bonvoisin C, Bouquegneau A, et al
    The Case | An unusual cause of renal vascular thrombi after kidney transplantation.
    Kidney Int. 2022;101:427-428.

    January 2022
  34. LOUIS K, Fadakar P, Macedo C, Yamada M, et al
    Concomitant loss of regulatory T and B cells is a distinguishing immune feature of antibody-mediated rejection in kidney transplantation.
    Kidney Int. 2022 Jan 25. pii: S0085-2538(22)00027.
    PubMed     Abstract available

  35. DUCLOUX D, Courivaud C
    REGEN-Cov antibody combination to prevent COVID-19 infection in kidney transplant recipient without detectable antibody response to optimal vaccine scheme.
    Kidney Int. 2022 Jan 4. pii: S0085-2538(21)01216.

  36. JEFFERIS J, Kassianos AJ, Grivei A, Doucet B, et al
    SARS-CoV-2 vaccination-associated collapsing glomerulopathy in a kidney transplant recipient.
    Kidney Int. 2022 Jan 4. pii: S0085-2538(21)01219.

  37. SALEM F, Perin L, Sedrakyan S, Angeletti A, et al
    The spatially resolved transcriptional profile of acute T cell-mediated rejection in a kidney allograft.
    Kidney Int. 2022;101:131-136.
    PubMed     Abstract available

    December 2021
  38. BENNING L, Morath C, Bartenschlager M, Reineke M, et al
    Natural SARS-CoV-2 infection results in higher neutralization response against variants of concern compared to two-dose BNT162b2 vaccination in kidney transplant recipients.
    Kidney Int. 2021 Dec 23. pii: S0085-2538(21)01169.

  39. SUGIANTO RI, Memaran N, Schmidt BMW, Doyon A, et al
    Insights from the 4C-T Study suggest increased cardiovascular burden in girls with end stage kidney disease before and after kidney transplantation.
    Kidney Int. 2021 Dec 21. pii: S0085-2538(21)01163.
    PubMed     Abstract available

  40. MENON R, Otto EA, Berthier CC, Nair V, et al
    Glomerular endothelial cell-podocyte stresses and crosstalk in structurally normal kidney transplants.
    Kidney Int. 2021 Dec 21. pii: S0085-2538(21)01162.
    PubMed     Abstract available

  41. LOUPY A, Mengel M, Haas M
    30 years of the International Banff Classification for Allograft Pathology: The Past, Present and Future of Kidney Transplant Diagnostics.
    Kidney Int. 2021 Dec 16. pii: S0085-2538(21)01142.
    PubMed     Abstract available

  42. CALLEMEYN J, Lamarthee B, Koenig A, Koshy P, et al
    Allorecognition and the spectrum of kidney transplant rejection.
    Kidney Int. 2021 Dec 13. pii: S0085-2538(21)01143.
    PubMed     Abstract available

  43. MASSET C, Ville S, Garandeau C, Le Borgne F, et al
    Observations on improving COVID-19 vaccination responses in kidney transplant recipients: heterologous vaccination and immunosuppression modulation.
    Kidney Int. 2021 Dec 8. pii: S0085-2538(21)01136.

  44. HEYBELI C, Bentall A, Wen J, Alexander MP, et al
    Corrigendum to Heybeli C, Bentall A, Wen J, et al. A study from The Mayo Clinic evaluated long-term outcomes of kidney transplantation in patients with immunoglobulin light chain amyloidosis. Kidney Int. 2021;99:707-715.
    Kidney Int. 2021;100:1348-1349.

    November 2021
  45. ASHCROFT J, Leighton P, Elliott TR, Hosgood SA, et al
    Extracellular Vesicles in Kidney Transplantation: A State of the Art Review.
    Kidney Int. 2021 Nov 25. pii: S0085-2538(21)01082.
    PubMed     Abstract available

    October 2021
  46. YI Z, Salem F, Menon MC, Keung K, et al
    Deep learning identified pathological abnormalities predictive of graft loss in kidney transplant biopsies.
    Kidney Int. 2021 Oct 29. pii: S0085-2538(21)01025.
    PubMed     Abstract available

  47. BERTRAND D, Hamzaoui M, Lemee V, Lamulle J, et al
    Antibody and T cell response to a third dose of SARS-CoV-2 messenger RNA BNT162b2 vaccine in kidney transplant recipients.
    Kidney Int. 2021 Oct 4. pii: S0085-2538(21)00924.

  48. DUCLOUX D, Courivaud C
    Should vaccination against COVID-19 be mandated in patients on the transplant waiting list?
    Kidney Int. 2021;100:939-940.

  49. LEFAUCHEUR C, Louis K, Philippe A, Loupy A, et al
    The emerging field of non-human leukocyte antigen antibodies in transplant medicine and beyond.
    Kidney Int. 2021;100:787-798.
    PubMed     Abstract available

    September 2021
  50. PEDERSEN RM, Bang LL, Tornby DS, Kierkegaard H, et al
    The SARS-CoV-2-neutralizing capacity of kidney transplant recipients 4 weeks after receiving a second dose of the BNT162b2 vaccine.
    Kidney Int. 2021 Sep 20. pii: S0085-2538(21)00866.

  51. WESTHOFF TH, Seibert FS, Anft M, Blazquez-Navarro A, et al
    A third vaccine dose substantially improves humoral and cellular SARS-CoV-2 immunity in renal transplant recipients with primary humoral non-response.
    Kidney Int. 2021 Sep 9. pii: S0085-2538(21)00850.

  52. AZZI Y, Raees H, Wang T, Cleare L, et al
    Risks factors associated with poor response to COVID-19 vaccination in kidney transplant recipients.
    Kidney Int. 2021 Sep 2. pii: S0085-2538(21)00826.

    August 2021
  53. DE GREEF J, Devresse A, Albichr IS, Scohy A, et al
    Better Late than Never: Eventual Seroconversion against SARS-CoV-2 in a Kidney Transplant Recipient after Repeated Immune Challenge and Monoclonal Antibody Therapy.
    Kidney Int. 2021 Aug 31. pii: S0085-2538(21)00825.

  54. MASSET C, Kerleau C, Garandeau C, Ville S, et al
    A third injection of BNT162b2 mRNA Covid-19 vaccine in kidney transplant recipients improves the humoral immune response.
    Kidney Int. 2021 Aug 30. pii: S0085-2538(21)00809.

  55. CHAVAROT N, Parize P, Podglajen I, Sberro-Soussan R, et al
    The Case | Cardiac tamponade in a kidney transplant recipient with chronic inflammation.
    Kidney Int. 2021;100:487-488.

  56. MENGEL M, Lubetzky M
    Do we need to treat chronic active T cell-mediated rejection?
    Kidney Int. 2021;100:275-277.
    PubMed     Abstract available

  57. CAILLARD S, Chavarot N, Bertrand D, Kamar N, et al
    Occurrence of severe COVID-19 in vaccinated transplant patients.
    Kidney Int. 2021;100:477-479.

  58. ARYKBAEVA AS, de Vries DK, Doppenberg JB, Engelse MA, et al
    Metabolic needs of the kidney graft undergoing normothermic machine perfusion.
    Kidney Int. 2021;100:301-310.
    PubMed     Abstract available

  59. KUNG VL, Sandhu R, Haas M, Huang E, et al
    Chronic active T cell-mediated rejection is variably responsive to immunosuppressive therapy.
    Kidney Int. 2021;100:391-400.
    PubMed     Abstract available

  60. SENEV A, Van Loon E, Lerut E, Callemeyn J, et al
    Risk factors, histopathological features, and graft outcome of transplant glomerulopathy in the absence of donor-specific HLA antibodies.
    Kidney Int. 2021;100:401-414.
    PubMed     Abstract available

    July 2021
  61. TAMBUR AR, Kosmoliaptsis V, Claas FH, Mannon RB, et al
    Significance of HLA-DQ in kidney transplantation - Time to re-evaluate HLA matching priorities to improve transplant outcomes? An expert review and recommendations.
    Kidney Int. 2021 Jul 8. pii: S0085-2538(21)00657.
    PubMed     Abstract available

  62. DALOUL R, Pesavento T, Goldberg DS, Reese PP, et al
    A Review of kidney transplantation from HCV-Viremic Donors into Negative Recipients.
    Kidney Int. 2021 Jul 5. pii: S0085-2538(21)00669.
    PubMed     Abstract available

    APOL1 genotyping in kidney transplantation: a look into the future.
    Kidney Int. 2021;100:32-34.

  64. KUMAR V, Locke JE
    APOL1 genotyping in kidney transplantation: to do or not to do, that is the question? (contra).
    Kidney Int. 2021;100:30-32.

  65. FREEDMAN BI, Poggio ED
    APOL1 genotyping in kidney transplantation: to do or not to do, that is the question? (pro).
    Kidney Int. 2021;100:27-30.

  66. YAMADA M, Iwamoto H, Konno O, Kihara Y, et al
    Pelvic arteriovenous malformation in a kidney transplant recipient.
    Kidney Int. 2021;100:246.

  67. BERCHTOLD L, Letouze E, Alexander MP, Canaud G, et al
    Corrigendum to Berchtold L, Letouze E, Alexander MP, et al. HLA-D and PLA2R1 risk alleles associate with recurrent primary membranous nephropathy in kidney transplant recipients. Kidney Int. 2021;99:671-685.
    Kidney Int. 2021;100:243.

    June 2021
  68. IKIZLER TA, Coates PT, Rovin BH, Ronco P, et al
    Immune response to SARS-CoV-2 infection and vaccination in patients receiving kidney replacement therapy.
    Kidney Int. 2021;99:1275-1279.
    PubMed     Abstract available

  69. RAMSPEK CL, El Moumni M, Wali E, Heemskerk MBA, et al
    Development and external validation study combining existing models and recent data into an up-to-date prediction model for evaluating kidneys from older deceased donors for transplantation.
    Kidney Int. 2021;99:1459-1469.
    PubMed     Abstract available

    May 2021
  70. DOLFF S, Baotong Z, Korth J, De L, et al
    Evidence of Cell Mediated Immune response in kidney transplants with negative mRNA-1273 Antibody Response.
    Kidney Int. 2021 May 21. pii: S0085-2538(21)00511.

  71. THIRUNAVUKKARASU B, Nada R, Ramachandran R, Sakhuja V, et al
    Epstein-Barr virus-associated hepatic smooth muscle tumor post-renal transplant.
    Kidney Int. 2021;99:1245.

  72. LIANG EN W, Tan CS, Conceicao EP, Venkatachalam I, et al
    Zero health care-associated respiratory viral infections: impact of enhanced infection prevention on a renal unit during the coronavirus disease 2019 pandemic.
    Kidney Int. 2021;99:1236-1238.

  73. SOTOMAYOR CG, Groothof D, Vodegel JJ, Eisenga MF, et al
    Plasma cadmium is associated with increased risk of long-term kidney graft failure.
    Kidney Int. 2021;99:1213-1224.
    PubMed     Abstract available

  74. DUJARDIN A, Lorent M, Foucher Y, Legendre C, et al
    Time-dependent lymphocyte count after transplantation is associated with higher risk of graft failure and death.
    Kidney Int. 2021;99:1189-1201.
    PubMed     Abstract available

    April 2021
  75. CHANG CC, Vlad G, Vasilescu ER, Husain SA, et al
    Disparity between levels of anti-RBD IgG and anti-nucleocapsid protein IgG antibodies in COVID-19-recovered patients who received a kidney transplant.
    Kidney Int. 2021 Apr 30. pii: S0085-2538(21)00457.

  76. PUTTARAJAPPA CM, Jorgensen D, Yabes JG, Jeong K, et al
    Trends and impact on cold ischemia time and clinical outcomes using virtual crossmatch for deceased donor kidney transplantation in the United States.
    Kidney Int. 2021 Apr 30. pii: S0085-2538(21)00460.
    PubMed     Abstract available

  77. DEL BELLO A, Marion O, Delas A, Congy-Jolivet N, et al
    Acute rejection after anti-SARS-CoV-2 mRNA vaccination in a kidney-transplant patient.
    Kidney Int. 2021 Apr 28. pii: S0085-2538(21)00466.

  78. CLAUDIO P, Rosaria CM
    The inflammatory state is a risk factor for cardiovascular disease and graft fibrosis in kidney transplantation.
    Kidney Int. 2021 Apr 28. pii: S0085-2538(21)00454.
    PubMed     Abstract available

  79. BENOTMANE I, Gautier-Vargas G, Cognard N, Olagne J, et al
    Low immunization rates among kidney transplant recipients who received two doses of the mRNA-1273 SARS-CoV-2 vaccine.
    Kidney Int. 2021 Apr 19. pii: S0085-2538(21)00389.

  80. COOREY CP, Sharma A, Muller S, Yang JYH, et al
    Prediction modeling-part 2: using machine learning strategies to improve transplantation outcomes.
    Kidney Int. 2021;99:817-823.
    PubMed     Abstract available

    November 2020
  81. TURNER MP, Storey BC, Mittal S, Macanovic J, et al
    Candida crescents in a renal allograft.
    Kidney Int. 2020;98:1356.

    May 2020
  82. ZHANG Z, Menon MC, Zhang W, Stahl E, et al
    Genome-wide non-HLA donor-recipient genetic differences influence renal allograft survival via early allograft fibrosis.
    Kidney Int. 2020 May 23. pii: S0085-2538(20)30540.
    PubMed     Abstract available

    January 2020
  83. SIGOGNE M, Culty T, Meria P, Demiselle J, et al
    Encrusted pyelitis in a kidney allograft.
    Kidney Int. 2020;97:217.

  84. PERAZELLA MA, Shirali AC
    Immune checkpoint inhibitor nephrotoxicity: what do we know and what should we do?
    Kidney Int. 2020;97:62-74.
    PubMed     Abstract available

Thank you for your interest in scientific medicine.

AMEDEO Kidney Transplantation is free of charge.
This policy is made possible thanks to a media sponsorship by Boehringer Ingelheim.